Southwest Heart
About Southwest Heart
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bristol-Myers Squibb
2
Gilead Sciences
2
ARYx Therapeutics
1
Cardium Therapeutics
1
Hartford Hospital
1
Midwest Heart Foundation
1
Clinical Trials at Southwest Heart
During the past decade, Southwest Heart conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?
2004-06-01
2010-12-01
Completed
824
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
2006-12-31
2011-05-25
Completed
20,976
Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization
2007-05-01
Unknown status
300
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
2007-08-31
2017-05-25
Completed
6,421
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
2008-05-01
2009-06-01
Unknown status
600
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Southwest Heart" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Gilead Sciences" with 2 trials
sponsored, "ARYx Therapeutics" with 1 trials sponsored, "Cardium Therapeutics" with 1 trials sponsored and "Hartford Hospital"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Heart"
#1 collaborator was "GE Healthcare" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Southwest Heart
According to Clinical.Site data, the most researched conditions in "Southwest Heart" are
"Atrial Fibrillation" (3 trials), "Atrial Flutter" (2 trials), "Coronary Artery Disease" (2 trials), "Hypertension" (2 trials) and "Angina Pectoris" (1 trials). Many other conditions were trialed in "Southwest Heart" in a lesser frequency.
Clinical Trials Intervention Types at Southwest Heart
Most popular intervention types in "Southwest Heart" are "Drug" (5 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials), "ATI-5923" (1 trials), "Acetylsalicylic acid" (1 trials) and "Ad5FGF-4" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Southwest Heart
The vast majority of trials in "Southwest Heart" are
5 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Southwest Heart
Currently, there are NaN active trials in "Southwest Heart".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Southwest Heart,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Southwest Heart, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".